Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
Anticancer Research|July 3, 2019
S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal CarcinomaTakahiko Ito, Yoshitaka Honma, Hidekazu Hirano, et al.
Cancers|March 10, 2022
Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine NeoplasmsDaisuke Takayanagi, Hourin Cho, Erika Machida, et al.
International Journal of Clinical Oncology|May 19, 2023
Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancerJun Imaizumi, Dai Shida, Narikazu Boku, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 4, 2019
Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancerToshifumi Yamaguchi, Satoru Iwasa, Hirokazu Shoji, et al.
Cancer Medicine|October 31, 2025
A Retrospective Analysis of the Efficacy and Safety of Imatinib for Advanced Gastrointestinal Stromal Tumor in Elderly PatientsTakahito Awatsu, Hidekazu Hirano, Kengo Nagashima, et al.
Journal of Cancer Research and Clinical Oncology|October 17, 2013
Impact of adding cisplatin to S-1 in elderly patients with advanced gastric cancerTetsuji Terazawa, Satoru Iwasa, Atsuo Takashima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 29, 2013
Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology group trials JCOG9205 and JCOG9912Atsuo Takashima, Narikazu Boku, Ken Kato, et al.
Anticancer Research|August 9, 2015
Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic SignificanceHirokazu Shoji, Yasuhide Yamada, Natsuko Okita, et al.
BMC Cancer|November 12, 2020
Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancerYasuyuki Takamizawa, Dai Shida, Narikazu Boku, et al.
Pageof 19